Skip to content

LES PHARMACIES LAMBRECHTS: what changed

BE 0448.543.638NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€270,032
2024 · €219,109+€50,923
Equity
€469,117
2024 · €324,085+€145,032
Cash
€339,422
2024 · €253,737+€85,685
Balance sheet total
€896,725
2024 · €809,793+€86,932

Largest movements

2024 to 2025
Assets
  • Cash +€85,685

    up €85,685 (+33.8%), from €253,737 to €339,422

    mainly Net result for the year (+€270,032) and Receivables within one year (+€39,639)

  • Receivables within one year -€39,639

    down €39,639 (-14.1%), from €281,770 to €242,131

    of which Trade receivables: -€20,831

  • Stocks and contracts +€23,195

    up €23,195 (+14.1%), from €164,082 to €187,277

  • Deferred charges and accrued income +€11,293

    up €11,293 (+1,100%), from €1,026 to €12,320

Equity and liabilities
  • Profit (loss) carried forward +€145,032

    up €145,032 (+63.9%), from €226,815 to €371,847

  • Trade debts -€47,737

    down €47,737 (-17.9%), from €266,697 to €218,960

  • Other debts -€37,032

    down €37,032 (-19.5%), from €189,721 to €152,689

  • Tax, wage and social debts +€14,209

    up €14,209 (+48.5%), from €29,290 to €43,499

    of which Remuneration and social security: +€14,672

  • Current portion of long-term debt +€12,460

    first reported in 2025, at €12,460

Income statement
  • Gross operating margin +€80,805

    up €80,805 (+18.7%), from €432,285 to €513,090

  • Taxes +€28,280

    up €28,280 (+126%), from €22,444 to €50,724

  • Depreciation +€6,998

    up €6,998 (+109%), from €6,411 to €13,409

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €219,109
Gross operating margin +€80,805
Staff costs +€2,217
Depreciation -€6,998
Other operating charges -€1
Financial income +€2,731
Financial charges +€450
Taxes -€28,280
Result 2025 €270,032
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€218,032
Investment -€19,806
Financing -€112,540
Cash 2024 €253,737
Net result for the year +€270,032
Depreciation +€13,409
Stocks and contracts -€23,195
Receivables within one year +€39,639
Deferred charges and accrued income -€11,293
Trade debts -€47,737
Tax, wage and social debts +€14,209
Other debts -€37,032
Investment in fixed assets (net) -€19,806
Current portion of long-term debt +€12,460
Contributions, distributions and other -€125,000
Cash 2025 €339,422
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €809,793 €896,725 +€86,932 +10.7%
Fixed assets 21/28 €39,178 €45,575 +€6,397 +16.3%
Tangible fixed assets 22/27 €39,178 €45,575 +€6,397 +16.3%
Plant, machinery and equipment 23 €20,061 €24,062 +€4,001 +19.9%
Furniture and vehicles 24 €19,117 €21,513 +€2,396 +12.5%
Current assets 29/58 €770,615 €851,150 +€80,535 +10.5%
Amounts receivable after more than one year 29 €70,000 €70,000 = 0.0%
Other amounts receivable 291 €70,000 €70,000 = 0.0%
Stocks and contracts in progress 3 €164,082 €187,277 +€23,195 +14.1%
Stocks 30/36 €164,082 €187,277 +€23,195 +14.1%
Amounts receivable within one year 40/41 €281,770 €242,131 -€39,639 -14.1%
Trade receivables 40 €238,437 €217,606 -€20,831 -8.7%
Other amounts receivable 41 €43,332 €24,525 -€18,808 -43.4%
Cash at bank and in hand 54/58 €253,737 €339,422 +€85,685 +33.8%
Deferred charges and accrued income 490/1 €1,026 €12,320 +€11,293 +1,100%
Total equity and liabilities 10/49 €809,793 €896,725 +€86,932 +10.7%
Equity 10/15 €324,085 €469,117 +€145,032 +44.8%
Contributions 10/11 €72,881 €72,881 = 0.0%
Capital 10 €72,881 €72,881 = 0.0%
Issued capital 100 €72,881 €72,881 = 0.0%
Reserves 13 €24,389 €24,389 = 0.0%
Non-distributable reserves 130/1 €7,290 €7,290 = 0.0%
Legal reserve 130 €7,288 €7,288 = 0.0%
Reserves not available under the articles 1311 €2 €2 = 0.0%
Tax-exempt reserves 132 €17,099 €17,099 = 0.0%
Profit (loss) carried forward 14 €226,815 €371,847 +€145,032 +63.9%
Amounts payable 17/49 €485,708 €427,608 -€58,100 -12.0%
Amounts payable within one year 42/48 €485,708 €427,608 -€58,100 -12.0%
Current portion of amounts payable after more than one year 42 - €12,460 +€12,460
Trade debts 44 €266,697 €218,960 -€47,737 -17.9%
Suppliers 440/4 €266,697 €218,960 -€47,737 -17.9%
Taxes, remuneration and social security 45 €29,290 €43,499 +€14,209 +48.5%
Taxes 450/3 €8,209 €7,746 -€463 -5.6%
Remuneration and social security 454/9 €21,081 €35,753 +€14,672 +69.6%
Other amounts payable 47/48 €189,721 €152,689 -€37,032 -19.5%
Remuneration, social security and pensions 62 €182,009 €179,792 -€2,217 -1.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €6,411 €13,409 +€6,998 +109%
Other operating charges 640/8 €2 €3 +€1 +51.2%
Gross operating margin 9900 €432,285 €513,090 +€80,805 +18.7%
Operating profit (loss) 9901 €243,863 €319,885 +€76,022 +31.2%
Financial income 75/76B €69 €2,800 +€2,731 +3,931%
Recurring financial income 75 €69 €2,800 +€2,731 +3,931%
Financial charges 65/66B €2,380 €1,930 -€450 -18.9%
Recurring financial charges 65 €2,380 €1,930 -€450 -18.9%
Profit (loss) for the period before taxes 9903 €241,553 €320,755 +€79,203 +32.8%
Income taxes 67/77 €22,444 €50,724 +€28,280 +126%
Profit (loss) for the period 9904 €219,109 €270,032 +€50,923 +23.2%
Profit (loss) for the period to be appropriated 9905 €219,109 €270,032 +€50,923 +23.2%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€938,683 to €1.2m

Midpoint €1.1m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €469,117
Capitalised earnings €1.4m to €2.0m
Indication €938,683 to €1.2m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€469,117
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€469,117

Capitalised earnings

net result for the year (9904)
2025
€270,032
2024
€219,109
2023
€102,324
2022
€54,249
excluding non-recurring income and charges
€53,069
2021
€42,387
excluding non-recurring income and charges
€37,649
Average result
€197,155
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.4m / €1.6m / €2.0m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.